Trial data help clarify role of ICDs (implantable defribrillators) in heart disease
This article was originally published in Clinica
Executive Summary
Further analysis of the latest in a succession of large clinical trials analysing the benefits of the implantable defibrillator (ICD) has found that while patients at high risk of cardiac arrest or cardiac death do benefit, those at low risk may not be worthy candidates for these expensive devices.